MANUFACTURERS LIFE INSURANCE COMPANY, THE - BROOKLYN IMMUNOTHERAPEUTICS ownership

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 46 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q4 2021$56,000
-63.4%
13,383
-18.6%
0.00%
Q3 2021$153,000
-39.3%
16,451
+17.5%
0.00%
Q2 2021$252,00014,0040.00%
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q2 2021.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders